An-tzu Jao
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes.
Journal: Diabetes & metabolism
Published: July 16, 2025
GLP-1 receptor agonists and risk of hepatocellular carcinoma and all-cause mortality in patients with MASLD and type 2 diabetes: a propensity score-matched population-based cohort study.
Journal: Diabetes research and clinical practice
Published: July 06, 2025
Assessing mortality risk in Type 2 Diabetes patients with prolonged ASCVD risk factors: the inclusive Poh-Ai predictive scoring system with CAC Score integration.
Journal: Diabetology & metabolic syndrome
Published: February 28, 2024
Predictors for Failed Removal of Nasogastric Tube in Patients With Brain Insult.
Journal: Annals of rehabilitation medicine
Published: November 01, 2023
The Protective Effect of Vitamin D on Dementia Risk in Hemodialysis Patients.
Journal: Life (Basel, Switzerland)
Published: July 18, 2023
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes.
Journal: Diabetes & metabolism
Published: February 13, 2023
Maintenance chemotherapy for esophageal squamous cell carcinoma after standard concurrent chemoradiotherapy: a national propensity score matching cohort study.
Journal: American journal of cancer research
Published: January 15, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026